KK-LC-1 TCR-T cells
- Generic Name
- KK-LC-1 TCR-T cells
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
Phase 1
Recruiting
- Conditions
- Gastric CancerCervical CancerBreast CancerLung Cancer
- Interventions
- First Posted Date
- 2022-08-02
- Last Posted Date
- 2025-03-30
- Lead Sponsor
- Christian Hinrichs
- Target Recruit Count
- 30
- Registration Number
- NCT05483491
- Locations
- 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
🇺🇸RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath